triple glp-1/gip/glucagon receptor agonist retatrutide glp-1 gip glucagon phase 2 trial obesity First-in-Class 'Triple-G'! Retatrutide, a first-in-class GIP, & hormone A once-daily GLP-1/GIP/glucagon receptor tri-agonist
Pay in 4 interest-free payments of $5.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3




















%20(1).png)



